These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 12389424)

  • 1. [Immunization coverage for measles, mumps and rubella in Italy: many shadows, few lights].
    Vellucci L
    Ann Ig; 2002; 14(4 Suppl 4):51-6. PubMed ID: 12389424
    [No Abstract]   [Full Text] [Related]  

  • 2. [The epidemiological impact of vaccination strategies in the Lazio Region].
    Faustini A; Giorgi-Rossi P; Sangalli M; Spadea T; Perucci CA
    Ann Ig; 2002; 14(4 Suppl 4):39-49. PubMed ID: 12389423
    [No Abstract]   [Full Text] [Related]  

  • 3. [Epidemiologic study of measles, rubella and mumps with regard to the possibility of their control by immunization].
    Rodríguez Borrego MJ; García León J; Bolumar F; Nájera E
    Rev Sanid Hig Publica (Madr); 1985; 59(1-2):117-25. PubMed ID: 4059834
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of vaccination with measles-mumps-rubella vaccine at 9, 12, and 15 months of age.
    Redd SC; King GE; Heath JL; Forghani B; Bellini WJ; Markowitz LE
    J Infect Dis; 2004 May; 189 Suppl 1():S116-22. PubMed ID: 15106100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of IgG antibody against measles, mumps and rubella in bangladeshi children: a pilot study to evaluate the need for integrated vaccination strategy.
    Sultana R; Rahman MM; Hassan Z; Hassan MS
    Scand J Immunol; 2006 Dec; 64(6):684-9. PubMed ID: 17083626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MMR vaccination: new thought.
    Deshmukh V
    Indian Pediatr; 2006 Jun; 43(6):555-6. PubMed ID: 16820670
    [No Abstract]   [Full Text] [Related]  

  • 7. An economic analysis of the current universal 2-dose measles-mumps-rubella vaccination program in the United States.
    Zhou F; Reef S; Massoudi M; Papania MJ; Yusuf HR; Bardenheier B; Zimmerman L; McCauley MM
    J Infect Dis; 2004 May; 189 Suppl 1():S131-45. PubMed ID: 15106102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ACIP issues recommendations to eliminate measles, rubella and congenital rubella syndrome and to control mumps.
    Rose VL
    Am Fam Physician; 1998 Nov; 58(7):1682, 1685-6. PubMed ID: 9824963
    [No Abstract]   [Full Text] [Related]  

  • 9. [Prevalence of antibodies and vaccination against measles, mumps and rubella in Polish population].
    Janaszek-Seydlitz W; Bucholc B; Wysokińska T; Górska P; Gniadek G
    Przegl Epidemiol; 2003; 57(2):281-8. PubMed ID: 12910596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Measles, mumps, rubella: important health risks].
    Rev Infirm; 2000 Oct; (64):13-5. PubMed ID: 11288443
    [No Abstract]   [Full Text] [Related]  

  • 11. Scandinavian model for eliminating measles, mumps, and rubella.
    Rabo E; Taranger J
    Br Med J (Clin Res Ed); 1984 Nov; 289(6456):1402-4. PubMed ID: 6437574
    [No Abstract]   [Full Text] [Related]  

  • 12. Pervasive developmental disorders in Montreal, Quebec, Canada: prevalence and links with immunizations.
    Fombonne E; Zakarian R; Bennett A; Meng L; McLean-Heywood D
    Pediatrics; 2006 Jul; 118(1):e139-50. PubMed ID: 16818529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Plan for the elimination of measles, mumps and rubella].
    Rabo E
    Lakartidningen; 1981 Aug; 78(34):2840-4. PubMed ID: 7321667
    [No Abstract]   [Full Text] [Related]  

  • 14. Why do parents hesitate to vaccinate their children against measles, mumps and rubella?
    Alfredsson R; Svensson E; Trollfors B; Borres MP
    Acta Paediatr; 2004 Sep; 93(9):1232-7. PubMed ID: 15384890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term immunity to measles, mumps and rubella after MMR vaccination among children with bone marrow transplants.
    Spoulou V; Giannaki M; Vounatsou M; Bakoula C; Grafakos S
    Bone Marrow Transplant; 2004 Jun; 33(12):1187-90. PubMed ID: 15077129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Rubella, measles and mumps. Epidemiology and prophylaxis (author's transl)].
    Zardi O
    Ann Sclavo; 1978; 20(4):487-509. PubMed ID: 753125
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Could the MMR vaccine replace the measles vaccine at one year of age in Egypt?
    Abbassy AA; Barakat SS; Abd El Fattah MM; Said ZN; El Metwally HA
    East Mediterr Health J; 2009; 15(1):85-93. PubMed ID: 19469430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for undervaccination against measles in a large sample of preschool children from rural Bavaria.
    Zucs AP; Crispin A; Eckl E; Weitkunat R; Schlipköter U
    Infection; 2004 Jun; 32(3):127-33. PubMed ID: 15188070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccination programme for eradication of measles, mumps, and rubella.
    Taranger J
    Lancet; 1982 Apr; 1(8277):915-6. PubMed ID: 6122137
    [No Abstract]   [Full Text] [Related]  

  • 20. Global measles elimination efforts: the significance of measles elimination in the United States.
    Strebel PM; Henao-Restrepo AM; Hoekstra E; Olive JM; Papania MJ; Cochi SL
    J Infect Dis; 2004 May; 189 Suppl 1():S251-7. PubMed ID: 15106119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.